Searched for
OBESITY DRUG STOCK MARKET NEWS
Bryan Johnson disease: The autoimmune condition that can increase cancer risk over time and often goes undetected. Check causes, symptoms, treatment and other detailsBryan Johnson autoimmune disease: Anti-aging personality Bryan Johnson's recent revelation of autoimmune disease has ignited public interes...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 25%As the market makes an attempt to move upward, there is a clear preference for sectors that are focused on the domestic market. Given this,...
- India to host two-day BRICS anti-drug agencies meet in Guwahati from July 6Guwahati will host a crucial two-day BRICS meeting from July 6, bringing together anti-drug agency heads to bolster intelligence sharing an...
- ‘Nobody should be left alone with a strong drug and a printout’: After Ketto, Kunal Kapoor’s next healthcare betAfter helping families finance critical treatments through Ketto, Kunal Kapoor is now focused on preventing those medical emergencies befor...
- US Stock Market: Fed minutes, corporate earnings to set the tone for Wall Street this weekInvestors will focus on the U.S. Federal Reserve's meeting minutes and the start of the second-quarter earnings season this week to gauge t...
- Tips from Britain's ‘Own Buffett’: Timeless investing lessons for building long-term wealthLegendary investor Anthony Bolton, famed for nearly 20% annual returns, reveals his secrets to market outperformance. He stresses temperame...
- Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcareFive young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials containe...
- Sun Pharma secures relief in 'Pantocid' trademark disputeDelhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'P...
- Sensex jumps 262 points, Nifty closes above 24,270. 7 key factors behind today's D-Street gainsIndian stock markets surged on Friday, with Sensex and Nifty climbing over 0.3% each. This rally was fueled by easing Middle East tensions,...
- South Korean shares rebound 6% but face second weekly lossSouth Korean equities rebounded sharply on Friday, with the Kospi jumping nearly 6%, led by strong gains in heavyweight stocks like Samsung...
- Why Nebius & CoreWeave stocks tumbled after Meta's AI cloud plans
- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- Stocks in news: Hero MotoCorp, Canara Bank, Bharti Airtel, Indian Hotels, SBIIndian markets opened positively, with analysts suggesting a stock-specific strategy amidst consolidation. Hero MotoCorp sees a revival in ...
- US Stock Market: US Supreme Court shields Fed independence, but leaves central bank more isolatedThe US Supreme Court has reaffirmed the Federal Reserve’s independence by blocking attempts to allow presidential removal of its governors ...
- Nestle to cut artificial colourings from all products by end-2026Nestle is set to eliminate all artificial food colorings globally by the end of 2026, a significant move by the major food producer. This i...
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
- Sensex rises over 200 points, Nifty above 24,000; Maruti Suzuki shares jump 3%Indian stock markets rebounded on Tuesday, with both Sensex and Nifty climbing approximately 0.4% after a dip in the previous session. The ...
- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
Load More
